ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jakob Vinten-Johansen
Stephen A. Mills
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vinten-Johansen, J.
Right arrow Articles by Cordell, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vinten-Johansen, J.
Right arrow Articles by Cordell, A. R.

Ann Thorac Surg 1988;45:319-326
© 1988 The Society of Thoracic Surgeons


Articles

Myocardial Protection with Blood Cardioplegia in Ischemically Injured Hearts: Reduction of Reoxygenation Injury with Allopurinol

Jakob Vinten-Johansen, Ph.D.*, Virginia Chiantella, M.D., Kirk B. Faust, M.D., William E. Johnston, M.D., Brenda L. McCain, M.D., Mark Hartman, M.D., Stephen A. Mills, M.D., T. Oma Hester, B.S., A. Robert Cordell, M.D.

From the Departments of Surgery (Section on Cardiothoracic Surgery) and Anesthesia, Bowman Gray School of Medicine, Wake Forest University Medical Center, Winston-Salem, NC

Accepted for publication November 10, 1987.

* Address reprint requests to Dr. Vinten-Johansen, Section on Cardiothoracic Surgery, Bowman Gray School of Medicine, 300 South Hawthorne Rd, Winston-Salem, NC 27103

Myocellular injury mediated by oxygen radicals potentially limits myocardial protection in ischemically damaged hearts. This damage may be greater with oxygen-carrying blood cardioplegic solutions. A major mechanism of oxygen radical production is the conversion of hypoxanthine to uric acid by xanthine oxidase. In 16 anesthetized dogs, we studied whether adding allopurinol, a xanthine oxidase inhibitor, to blood cardioplegia would improve recovery of left ventricular (LV) performance and oxygen consumption. Millar transducer-tipped catheters and minor axis ultrasonic crystals were placed to assess LV performance by the slope of the end-systolic pressure-minor axis diameter relationships (Emax). Following total vented bypass, the hearts underwent 30 minutes of normothermic ischemia and then hypothermic blood cardioplegia with 1 mM allopurinol (N = 8) or without allopurinol (N = 8). Postischemic LV performance was significantly better with allopurinol than without (49.5 ± 8.0 versus 17.4 ± 4.1% of preischemic Emax; p < 0.004). Postischemic LV oxygen consumption in the beating working state, calculated from LV blood flow (15-µm microspheres) and oxygen extraction, was comparable to preischemic values with and without allopurinol (10.2 ± 1.2 versus 8.6 ± 1.2 ml O2/100 gm/min). We conclude that allopurinol enhancement of blood cardioplegia increases myocardial protection in severely ischemic ventricles.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
P. Pacher, A. Nivorozhkin, and C. Szabo
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
Pharmacol. Rev., March 1, 2006; 58(1): 87 - 114.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. C. Cleveland Jr, D. R. Meldrum, R. T. Rowland, A. Banerjee, and A. H. Harken
Optimal Myocardial Preservation: Cooling, Cardioplegia, and Conditioning
Ann. Thorac. Surg., February 1, 1996; 61(2): 760 - 768.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
E. R. Rosenkranz
Substrate enhancement of cardioplegic solution: Experimental studies and clinical evaluation
Ann. Thorac. Surg., September 1, 1995; 60(3): 797 - 800.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Sisto, H. Paajanen, T. Metsa-Ketela, A. Harmoinen, I. Nordback, and M. Tarkka
Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting
Ann. Thorac. Surg., June 1, 1995; 59(6): 1519 - 1523.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Nakanishi, Z.-Q. Zhao, J. Vinten-Johansen, J. C. Lewis, D. S. McGee, and J. W. Hammon Jr
Coronary artery endothelial dysfunction after global ischemia, blood cardioplegia, and reperfusion
Ann. Thorac. Surg., July 1, 1994; 58(1): 191 - 199.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Vinten-Johansen, J. S. Julian, H. Yokoyama, W. E. Johnston, T. D. Smith, D. S. McGee, and A. R. Cordell
Efficacy of myocardial protection with hypothermic blood cardioplegia depends on oxygen
Ann. Thorac. Surg., October 1, 1991; 52(4): 939 - 948.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Yokoyama, J. S. Julian, J. Vinten-Johansen, W. E. Johnston, T. D. Smith, D. S. McGee, and A. R. Cordell
Postischemic [Ca2+] repletion improves cardiac performance without altering oxygen demands
Ann. Thorac. Surg., June 1, 1990; 49(6): 894 - 902.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. H. Cheung, J. M. Arcidi Jr, L. M. A. Dorsey, J. Vinten-Johansen, C. R. Hatcher Jr, and R. A. Guyton
Reperfusion of Infarcting Myocardium: Benefit of Surgical Reperfusion in a Chronic Model
Ann. Thorac. Surg., September 1, 1989; 48(3): 331 - 338.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The Society of Thoracic Surgeons.